Showing results (51-60 of 112) with videos related to
Sort By:
Pageof 12
Postgraduate Medical Journal|November 4, 1998
Pyrexia, anaemia and acute renal failure secondary to omeprazoleM J Landray, T Ringrose, R E Ferner, et al.Lancet (London, England)|July 8, 1989
Drugs in donated bloodR E Ferner, J A Dunstan, S Chaplin, et al.British Journal of Clinical Pharmacology|September 29, 2005
The quality of information on monitoring for haematological adverse drug reactionsR E Ferner, Jamie Coleman, Munir Pirmohamed, et al.Journal of Neurology, Neurosurgery, and Psychiatry|May 1, 1993
MRI in neurofibromatosis 1. The nature and evolution of increased intensity T2 weighted lesions and their relationship to intellectual impairmentR E Ferner, R Chaudhuri, J Bingham, et al.Journal of Clinical Pharmacy and Therapeutics|August 13, 2003
The safety of spironolactone treatment in patients with heart failureC Anton, A R Cox, R D S Watson, et al.Journal of Clinical Pharmacy and Therapeutics|January 30, 2004
Adverse drug reaction teaching in UK undergraduate medical and pharmacy programmesA R Cox, J F Marriott, K A Wilson, et al.Quality & Safety in Health Care|June 4, 2004
Improving prescribing using a rule based prescribing systemC Anton, P G Nightingale, D Adu, et al.European Journal of Radiology|May 20, 1998
Multiple lower limb non-ossifying fibromas in siblings with neurofibromatosisD C Howlett, M M Farrugia, R E Ferner, et al.Journal of Toxicology. Clinical Toxicology|June 24, 2000
Monitoring of clozapine and norclozapine plasma concentration-time curves in acute overdoseA C Renwick, A G Renwick, R J Flanagan, et al.Cardiovascular and Interventional Radiology|January 1, 1982
Fatal atheromatous embolization during coronary angiographyM R Nicholson, R E Ferner, H White, et al.Pageof 12